Rankings
▼
Calendar
ZTS Q1 2018 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
Q1 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.4B
+11.0% YoY
Gross Profit
$896M
65.6% margin
Operating Income
$461M
33.7% margin
Net Income
$352M
25.8% margin
EPS (Diluted)
$0.72
QoQ Revenue Growth
-6.4%
Cash Flow
Operating Cash Flow
$389M
Free Cash Flow
$336M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$8.7B
Total Liabilities
$6.7B
Stockholders' Equity
$2.0B
Cash & Equivalents
$1.7B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.4B
$1.2B
+11.0%
Gross Profit
$896M
$767M
+16.8%
Operating Income
$461M
$368M
+25.3%
Net Income
$352M
$238M
+47.9%
Revenue Segments
Dogs and Cats
$549M
40%
Cattle
$416M
31%
Swine
$175M
13%
Poultry
$136M
10%
Horses
$41M
3%
Fish
$22M
2%
Sheep and Other
$21M
2%
Geographic Segments
BRAZIL
$70M
24%
CHINA
$64M
22%
CANADA
$40M
13%
GERMANY
$38M
13%
FRANCE
$33M
11%
ITALY
$27M
9%
SPAIN
$25M
8%
← FY 2018
All Quarters
Q2 2018 →